Cargando…

Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study

BACKGROUND: Although early detection of lung cancer through screening is associated with better prognosis, most lung cancers are diagnosed among unscreened individuals. We therefore sought to characterize pathways to lung cancer diagnosis among unscreened individuals. METHODS: Participants were indi...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarty, Rachel D., Barnard, Mollie E., Lawson-Michod, Katherine A., Owens, Makelle, Green, Sarah E., Derzon, Samantha, Karabegovic, Lea, Akerley, Wallace L., Watt, Melissa H., Doherty, Jennifer A., Grieshober, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548694/
https://www.ncbi.nlm.nih.gov/pubmed/37789288
http://dx.doi.org/10.1186/s12875-023-02158-7
_version_ 1785115326050992128
author McCarty, Rachel D.
Barnard, Mollie E.
Lawson-Michod, Katherine A.
Owens, Makelle
Green, Sarah E.
Derzon, Samantha
Karabegovic, Lea
Akerley, Wallace L.
Watt, Melissa H.
Doherty, Jennifer A.
Grieshober, Laurie
author_facet McCarty, Rachel D.
Barnard, Mollie E.
Lawson-Michod, Katherine A.
Owens, Makelle
Green, Sarah E.
Derzon, Samantha
Karabegovic, Lea
Akerley, Wallace L.
Watt, Melissa H.
Doherty, Jennifer A.
Grieshober, Laurie
author_sort McCarty, Rachel D.
collection PubMed
description BACKGROUND: Although early detection of lung cancer through screening is associated with better prognosis, most lung cancers are diagnosed among unscreened individuals. We therefore sought to characterize pathways to lung cancer diagnosis among unscreened individuals. METHODS: Participants were individuals with lung cancer who did not undergo asymptomatic lung cancer screening (n = 13) and healthcare providers who may be involved in the pathway to lung cancer diagnosis (n = 13). We conducted semi-structured interviews to identify themes in lung cancer patients’ narratives of their cancer diagnoses and providers’ personal and/or professional experiences of various pathways to lung cancer diagnoses, to identify delays in diagnosis. We audio-recorded, transcribed, and coded interviews in two stages. First, we conducted deductive coding using three time-period intervals from the Models of Pathways to Treatment framework: appraisal, help-seeking, and diagnostic (i.e., excluding pre-treatment). Second, we conducted inductive coding to identify themes within each time-period interval, and classified these themes as either barriers or facilitators to diagnosis. Coding and thematic summarization were completed independently by two separate analysts who discussed for consensus. RESULTS: Eight of the patient participants had formerly smoked, and five had never smoked. We identified eight barrier/facilitator themes within the three time-period intervals. Within the appraisal interval, the barrier theme was (1) minimization or misattribution of symptoms, and the facilitator theme was (2) acknowledgment of symptoms. Within the help-seeking interval, the barrier theme was (3) hesitancy to seek care, and the facilitator theme was (4) routine care. Within the diagnosis interval, barrier themes were (5) health system challenges, and (6) social determinants of health; and facilitator themes were (7) severe symptoms and known risk factors, and (8) self-advocacy. Many themes were interrelated, including minimization or misattribution of symptoms and hesitancy to seek care, which may collectively contribute to care and imaging delays. CONCLUSIONS: Interventions to reduce hesitancy to seek care may facilitate timely lung cancer diagnoses. More prompt referral to imaging—especially computed tomography (CT)—among symptomatic patients, along with patient self-advocacy for imaging, may reduce delays in diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-023-02158-7.
format Online
Article
Text
id pubmed-10548694
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105486942023-10-05 Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study McCarty, Rachel D. Barnard, Mollie E. Lawson-Michod, Katherine A. Owens, Makelle Green, Sarah E. Derzon, Samantha Karabegovic, Lea Akerley, Wallace L. Watt, Melissa H. Doherty, Jennifer A. Grieshober, Laurie BMC Prim Care Research BACKGROUND: Although early detection of lung cancer through screening is associated with better prognosis, most lung cancers are diagnosed among unscreened individuals. We therefore sought to characterize pathways to lung cancer diagnosis among unscreened individuals. METHODS: Participants were individuals with lung cancer who did not undergo asymptomatic lung cancer screening (n = 13) and healthcare providers who may be involved in the pathway to lung cancer diagnosis (n = 13). We conducted semi-structured interviews to identify themes in lung cancer patients’ narratives of their cancer diagnoses and providers’ personal and/or professional experiences of various pathways to lung cancer diagnoses, to identify delays in diagnosis. We audio-recorded, transcribed, and coded interviews in two stages. First, we conducted deductive coding using three time-period intervals from the Models of Pathways to Treatment framework: appraisal, help-seeking, and diagnostic (i.e., excluding pre-treatment). Second, we conducted inductive coding to identify themes within each time-period interval, and classified these themes as either barriers or facilitators to diagnosis. Coding and thematic summarization were completed independently by two separate analysts who discussed for consensus. RESULTS: Eight of the patient participants had formerly smoked, and five had never smoked. We identified eight barrier/facilitator themes within the three time-period intervals. Within the appraisal interval, the barrier theme was (1) minimization or misattribution of symptoms, and the facilitator theme was (2) acknowledgment of symptoms. Within the help-seeking interval, the barrier theme was (3) hesitancy to seek care, and the facilitator theme was (4) routine care. Within the diagnosis interval, barrier themes were (5) health system challenges, and (6) social determinants of health; and facilitator themes were (7) severe symptoms and known risk factors, and (8) self-advocacy. Many themes were interrelated, including minimization or misattribution of symptoms and hesitancy to seek care, which may collectively contribute to care and imaging delays. CONCLUSIONS: Interventions to reduce hesitancy to seek care may facilitate timely lung cancer diagnoses. More prompt referral to imaging—especially computed tomography (CT)—among symptomatic patients, along with patient self-advocacy for imaging, may reduce delays in diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-023-02158-7. BioMed Central 2023-10-03 /pmc/articles/PMC10548694/ /pubmed/37789288 http://dx.doi.org/10.1186/s12875-023-02158-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
McCarty, Rachel D.
Barnard, Mollie E.
Lawson-Michod, Katherine A.
Owens, Makelle
Green, Sarah E.
Derzon, Samantha
Karabegovic, Lea
Akerley, Wallace L.
Watt, Melissa H.
Doherty, Jennifer A.
Grieshober, Laurie
Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title_full Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title_fullStr Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title_full_unstemmed Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title_short Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
title_sort pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548694/
https://www.ncbi.nlm.nih.gov/pubmed/37789288
http://dx.doi.org/10.1186/s12875-023-02158-7
work_keys_str_mv AT mccartyracheld pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT barnardmolliee pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT lawsonmichodkatherinea pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT owensmakelle pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT greensarahe pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT derzonsamantha pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT karabegoviclea pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT akerleywallacel pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT wattmelissah pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT dohertyjennifera pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy
AT grieshoberlaurie pathwaystolungcancerdiagnosisamongindividualswhodidnotreceivelungcancerscreeningaqualitativestudy